ALS Therapy Development Institute Adds Two Board Members
5/2/2013 7:50:58 AM
More...
|
ALS Therapy Development Institute Release: FDA Approves Clinical Trial of TDI-132 (Gilenyaв) in ALS Patients
2/11/2013 9:16:16 AM
More...
|
ALS Therapy Development Institute and To-BBB technologies BV Collaborate on Potential Treatments for Motor Neuron Disease
1/8/2013 10:10:07 AM
More...
|
ALS Therapy Development Institute and Gladstone Institute Collaborate to Discover Potential ALS Treatments
12/4/2012 9:50:38 AM
More...
|
ALS Therapy Development Institute Announces Research Agreement with Biogen Idec, Inc. (Massachusetts) (BIIB) and UCB Pharma (UCBJF.PK) to Investigate the Role of CD40L in ALS
12/19/2011 10:38:14 AM
More...
|
U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS Therapy Development Institute During Gala Event this November
6/7/2011 9:38:38 AM
More...
|
ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors
2/4/2011 9:52:54 AM
More...
|
ALS Therapy Development Institute and Oxford BioMedica PLC (OXB.L) Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
1/28/2010 7:57:44 AM
More...
|
ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
5/4/2009 7:51:54 AM
More...
|
ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease
8/19/2008 10:30:41 AM
More...
|
|